CSIMarket
 


Acorda Therapeutics Inc   (ACOR)
Other Ticker:  
 


Acorda Therapeutics Inc 's Effective Tax Rate by quarter

Trends, Rankings, Statistics



ACOR Effective Tax Rate (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Pre-Tax Income Change - - - - -
Seq. Pre-Tax Income Change - - - - -
Pre-Tax Income In Millions $-9.94 $-11.35 $-18.86 $21.57 $-12.44
Effective Tax Rate - - - 11.27 % -
Effective Tax Rate Total Ranking # # # # 397 #
Income taxes expenses / -benefit In Millions $-1.06 $-1.97 $-2.04 $2.43 $1.42
Y / Y Income taxes expenses / -benefit Change - - - 45.8 % -
Seq. Income taxes expenses / -benefit Change - - - 71.75 % -


Commenting Third Quarter 2023 Effective Tax Rate
Acorda Therapeutics Inc recieved tax benefit in III. Quarter .

Looking into III. Quarter results within Biotechnology & Pharmaceuticals industry Acorda Therapeutics Inc achieved lowest Effective Tax Rate. While total ranking remained unchanged compare to previous quarter at no. .

ACOR's Effective Tax Rate third quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

ACOR's Effective Tax Rate Statistics
High Average Low
157.83 % 43.35 % 4.53 %
(Sep 30 2018)   (Mar 31 2012)




Other Effective Tax Rate Profitability Ratios
ACOR's Cumulative Effective Tax Rate
Biotechnology & Pharmaceuticals Industry Effective Tax Rate Trends and Statistics
Healthcare Sector Effective Tax Rate Statistics
Effective Tax Rate Profitability Trends for overall market
ACOR's Effective Tax Rate Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Effective Tax Rate
Lowest Ranking Effective Tax Rate
Effective Tax Rate Profit Margin for ACOR's Competitors
Effective Tax Rate Profit Margin for Acorda Therapeutics Inc 's Suppliers
Effective Tax Rate Profit Margin for ACOR's Customers

You may also want to know
ACOR's Annual Growth Rates ACOR's Profitability Ratios ACOR's Asset Turnover Ratio ACOR's Dividend Growth
ACOR's Roe ACOR's Valuation Ratios ACOR's Financial Strength Ratios ACOR's Income taxes expenses / -benefit Growth
ACOR's Roa ACOR's Inventory Turnover Ratio ACOR's Growth Rates ACOR's Dividend Comparisons


Companies with similar Effective Tax Rate in the quarter ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Effective Tax RateSep 30 2023 MRQ Income taxes expenses / -benefitSep 30 2023 MRQ Pre-Tax Income
Neurocrine Biosciences Inc   28.11 %$ 32.500 $ 115.600 
Halozyme Therapeutics Inc   19.58 %$ 19.923 $ 101.760 
Enzon Pharmaceuticals inc   19.14 %$ 0.076 $ 0.397 
Amgen Inc   11.15 %$ 217.000 $ 1,947.000 
Gilead Sciences Inc   6.30 %$ 146.000 $ 2,318.000 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com